- Home
- IQV vs CCL Comparison
IQV vs CCL Comparison
Compare IQV & CCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IQV | CCL |
|---|---|---|
| Founded | 1982 | 1972 |
| Country | United States | United States |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.1B | 38.0B |
| IPO Year | 2013 | 1994 |
Fundamental Metrics
Financial Performance| Metric | IQV | CCL |
|---|---|---|
| Price | $262.33 | $25.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 22 |
| Target Price | ★ $227.13 | $33.99 |
| AVG Volume (30 Days) | 1.2M | ★ 16.2M |
| Earning Date | 05-05-2026 | 03-27-2026 |
| Dividend Yield | N/A | ★ 2.35% |
| EPS Growth | 4.67 | ★ 40.28 |
| EPS | ★ 1.61 | 0.57 |
| Revenue | $9,739,000,000.00 | ★ $18,881,000,000.00 |
| Revenue This Year | $6.77 | $5.69 |
| Revenue Next Year | $5.89 | $3.52 |
| P/E Ratio | $162.43 | ★ $44.89 |
| Revenue Growth | ★ 41.60 | 7.83 |
| 52 Week Low | $154.50 | $23.45 |
| 52 Week High | $262.51 | $34.03 |
Technical Indicators
Market Signals| Indicator | IQV | CCL |
|---|---|---|
| Relative Strength Index (RSI) | 73.47 | 35.37 |
| Support Level | $159.91 | $23.63 |
| Resistance Level | N/A | $28.22 |
| Average True Range (ATR) | 7.47 | 0.72 |
| MACD | 0.69 | -0.30 |
| Stochastic Oscillator | 92.06 | 1.57 |
Price Performance
Historical ComparisonAbout IQV IQVIA Holdings Inc.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
About CCL Carnival Corporation
Carnival is the largest global cruise company, with nearly 100 ships in service. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It recently folded its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted nearly 14 million guests in 2025.